Literature DB >> 25615410

Probing phase transitions in simvastatin with terahertz time-domain spectroscopy.

Nicholas Y Tan1, J Axel Zeitler.   

Abstract

Simvastatin is known to exist in at least three polymorphic forms. The nature of polymorphism in simvastatin is ambiguous, as the crystal structures of the polymorphs do not show any significant change in crystal packing or molecular conformation. We utilize terahertz time-domain spectroscopy to characterize each of the polymorphs and probe the phase transitions in the range of 0.2-3.0 THz and for temperatures ranging from 90 to 390 K. In form III, vibrational modes are observed at 1.0, 1.25, and 1.7 THz. For form I, we find that the spectrum is dominated by a baseline corresponding to libration-vibration motions coupled to the dielectric relaxations, which is characteristic of a disordered hydrogen bonding material but with additional broad vibrational modes at 0.8 and 1.4 THz. In addition, the baseline shifts with temperature similar to that observed in disordered materials. This background absorption exhibits pronounced changes around the phase transition temperatures at 232 and 272 K. The results are in agreement with molecular dynamics simulations, which indicate that changes in the rotational freedom of the ester tail in the molecule govern the polymorphism in simvastatin.

Entities:  

Keywords:  disordered crystal; phase transition; simvastatin; spectroscopy; terahertz

Mesh:

Substances:

Year:  2015        PMID: 25615410     DOI: 10.1021/mp500649q

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  2 in total

1.  Advanced therapeutic inhalation aerosols of a Nrf2 activator and RhoA/Rho kinase (ROCK) inhibitor for targeted pulmonary drug delivery in pulmonary hypertension: design, characterization, aerosolization, in vitro 2D/3D human lung cell cultures, and in vivo efficacy.

Authors:  Maria F Acosta; Priya Muralidharan; Carissa L Grijalva; Michael D Abrahamson; Don Hayes; Jeffrey R Fineman; Stephen M Black; Heidi M Mansour
Journal:  Ther Adv Respir Dis       Date:  2021 Jan-Dec       Impact factor: 5.158

2.  Prediction and Preparation of Coamorphous Phases of a Bislactam.

Authors:  Luke I Chambers; Osama M Musa; Jonathan W Steed
Journal:  Mol Pharm       Date:  2022-06-22       Impact factor: 5.364

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.